Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial
间充质干细胞疗法治疗重症 COVID-19 患者的长期疗效:一项随机、双盲、安慰剂对照试验的 3 年随访结果
期刊:Stem Cell Research & Therapy
影响因子:7.3
doi:10.1186/s13287-025-04148-1
Yuan, Meng-Qi; Song, Le; Wang, Ze-Rui; Zhang, Zi-Ying; Shi, Ming; He, Junli; Mo, Qiong; Zheng, Ning; Yao, Wei-Qi; Zhang, Yu; Dong, Tengyun; Li, Yuanyuan; Zhang, Chao; Song, Jinwen; Huang, Lei; Xu, Zhe; Yuan, Xin; Fu, Jun-Liang; Zhen, Cheng; Cai, Jianming; Dong, Jinghui; Zhang, Jianzeng; Xie, Wei-Fen; Li, Yonggang; Zhang, Bo; Shi, Lei; Wang, Fu-Sheng